We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CVS Health Corporation | NYSE:CVS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.46 | -1.03% | 44.03 | 44.43 | 43.78 | 44.24 | 3,262,367 | 16:27:22 |
10:24 ET -- CVS is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The healthcare giant reported third-quarter revenue of $89.76 billion and earnings of $1.75 a share, surpassing the expectations of analysts polled by FactSet. However, CVS dropped its guidance range for 2023 EPS to $6.37 to $6.61 a share, citing headwinds in key business segments. Dow Jones & Co. owns Factiva. (susan.solan@wsj.com)
(END) Dow Jones Newswires
November 01, 2023 10:39 ET (14:39 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year CVS Health Chart |
1 Month CVS Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions